Vaxxinity Inc Class A VAXX
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.03
- 52-Week Range
- $0.00–0.20
- Bid/Ask
- $0.36 / $0.40
- Shares Outstanding
- 126.78M
- Market Cap
- $11,291.06
- Volume/Avg
- 12,472 / 19,052
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based active immunotherapy medicines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company’s proprietary technology platform has enabled the innovation of novel pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 53
- Website
- https://www.vaxxinity.com
Valuation
|
Metric
|
VAXX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VAXX
|
|---|---|
Quick Ratio | 1.75 |
Current Ratio | 1.89 |
Interest Coverage | −83.80 |
Quick Ratio
VAXX
Profitability
|
Metric
|
VAXX
|
|---|---|
Return on Assets (Normalized) | −67.69% |
Return on Equity (Normalized) | −136.96% |
Return on Invested Capital (Normalized) | −101.16% |
Return on Assets
VAXX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|%!K!J?? | LOCK|bx#B< | $136B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Zmht@c | LOCK|Zp@j | $84B | |||
| Moderna Inc
MRNA
| LOCK|@>m#$QX | LOCK|&%b | $81B | |||
| argenx SE ADR
ARGX
| LOCK|F^l>$>! | LOCK|m<< | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|l>DY@F | LOCK|@Dn | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|XLwn&Yl | LOCK|FLY! | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^R#^x$t | LOCK|Fgt? | $28B | |||
| Incyte Corp
INCY
| LOCK|dRF@Bb | LOCK|&#S | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|P?dwK@S | LOCK|?P | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|j?>GDN$ | LOCK|%%X | $14B |
United States